TrialBlood advances2025

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.

Sameem Abedin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.